Nurses collect data from women and their families that may contribute to refining the risk factors for ovarian cancer and possibly identifying high-risk subgroups susceptible to these tumors.

Discussion was centred around ESMO 2022, where Dr Ray-Coquard presented ... long-term use of these has been shown to reduce the risk of ovarian cancer by 40% in middle-aged and elderly women.

AstraZeneca and Merck & Co’s Lynparza (olaparib) stole the headlines at ESMO after trial results showed it massively reduced the risk of BRCA-mutated ovarian cancer progressing in patients who ...

Risk factors – include Metabolic syndrome, obesity, diabetes, hormonal imbalance, polycystic ovarian disease, inability to have children, delaying childbirth. Family history of uterine cancer ...

Ovarian cancer remains one of the most challenging gynaecological cancers to detect and treat. While there is no definitive ...

Risk factors for ovarian cancer include: Being age 60 or older A family history breast cancer or ovarian cancer Having children later in life or never having a full-term pregnancy Taking hormone ...

Sara Orgill discusses her ovarian ... at Higher Risk A new Huntsman Cancer Institute study published in the Journal of Clinical Oncology shows frequent aspirin use is linked with lower ovarian cancer ...

The study used Cox proportional hazards models, adjusting for various risk factors, to analyze the relationship between air pollution and ovarian cancer. Limitations include the inability to ...

As for pursuing tissue factor and ... another key risk is that the 2025 expansion cohort update in ovarian cancer could see a similar "sell the news" reaction to this year's ESMO data.

Women who take hormonal contraceptives have a lower risk of womb and ovarian cancer ... According to Cancer Research UK, there are other, bigger avoidable risk factors for developing breast ...

Few modifiable risk factors for ovarian cancer have been identified. Environmental factors, including those associated with the workplace, may increase the risk, but relatively few studies have ...

Age at menarche is considered a weak predictor of ovarian cancer risk. A moderate increase in risk for ovarian cancer occurs in women when menarche begins earlier than age 12 years. [1,15] No ...